Related Experiment Videos
Assays of ADAMTS-13 activity
Agnès Veyradier1, Jean-Pierre Girma
1INSERM U.142, Hôpital de Bicêtre, Paris, France.
Seminars in Hematology
|January 17, 2004
Summary
Assays for ADAMTS-13 activity, crucial for diagnosing thrombotic thrombocytopenic purpura (TTP), involve substrate proteolysis and product quantification. Current methods are complex and slow, hindering rapid TTP diagnosis.
Area of Science:
- Biochemistry
- Hematology
- Diagnostic Assays
Background:
- Assays for ADAMTS-13 activity are essential for diagnosing thrombotic thrombocytopenic purpura (TTP).
- Existing methods involve substrate proteolysis followed by product quantification.
- These assays utilize various substrates like von Willebrand factor (VWF) and unfolding agents such as urea or guanidine.
Purpose of the Study:
- To review and analyze existing assays for determining ADAMTS-13 activity.
- To highlight the methodologies employed in these assays, including substrate preparation and detection methods.
- To discuss the limitations of current assays in the context of rapid laboratory diagnosis of TTP.
Main Methods:
- Proteolysis of VWF substrates (exogenous or endogenous) by ADAMTS-13.
- Substrate unfolding using urea or guanidine.
- Quantification of cleavage products or residual VWF via electrophoresis, functional assays, or immunoassays (ELISA, IRMA).
Main Results:
- Various methods exist for measuring ADAMTS-13 activity, all involving proteolysis and quantification steps.
- Assays have successfully linked deficient ADAMTS-13 activity to TTP since 1998.
- Current assays are cumbersome, time-consuming, and not yet ideal for rapid diagnosis.
Conclusions:
- Despite their utility in establishing the link between ADAMTS-13 and TTP, current assays require significant improvement.
- The complexity and time-intensive nature of these assays limit their routine use for rapid laboratory diagnosis.
- Further development is needed to create more efficient and physiologically relevant assays for ADAMTS-13 activity.